Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Dermatology

Journal Scan / Research · March 30, 2024

Clinical Outcomes of Treatment With Rituximab Plus Steroid-Sparing Therapy vs Rituximab Alone in Patients With Pemphigus

Journal of Drugs in Dermatology

 

Additional Info

Journal of Drugs in Dermatology
Comparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus
J Drugs Dermatol 2024 Mar 01;23(3)e97-e99, DE Mustin, EF Cole, R Leibowitz, RJ Feldman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading